Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M121,210Revenue (TTM) $M28,725Net Margin (%)12.7Altman Z-Score3.0
Enterprise Value $M140,539EPS (TTM) $2.6Operating Margin %18.5Piotroski F-Score6
P/E(ttm)34.1Beneish M-Score-2.5Pre-tax Margin (%)15.3Higher ROA y-yN
Price/Book2.410-y EBITDA Growth Rate %6.2Quick Ratio2.5Cash flow > EarningsY
Price/Sales4.35-y EBITDA Growth Rate %4.1Current Ratio3.0Lower Leverage y-yY
Price/Free Cash Flow26.0y-y EBITDA Growth Rate %13.6ROA % (ttm)3.6Higher Current Ratio y-yN
Dividend Yield %1.8PEG8.3ROE % (ttm)7.1Less Shares Outstanding y-yY
Payout Ratio %61.0Shares Outstanding M1,382ROIC % (ttm)6.3Gross Margin Increase y-yY

Gurus Latest Trades with MDT

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MDTBarrow, Hanley, Mewhinney & Strauss 2016-06-30 Reduce-0.73%$75 - $86.77
($80.78)
$ 87.719%Reduce -23.29%21,090,262
MDTT Rowe Price Equity Income Fund 2016-06-30 Buy 0.31%$75 - $86.77
($80.78)
$ 87.719%New holding750,000
MDTRobert Olstein 2016-06-30 Reduce-0.3%$75 - $86.77
($80.78)
$ 87.719%Reduce -31.25%66,000
MDTHOTCHKIS & WILEY 2016-06-30 Reduce-0.23%$75 - $86.77
($80.78)
$ 87.719%Reduce -30.34%1,653,662
MDTJoel Greenblatt 2016-06-30 Buy 0.17%$75 - $86.77
($80.78)
$ 87.719%New holding167,825
MDTVanguard Health Care Fund 2016-06-30 Add0.15%$75 - $86.77
($80.78)
$ 87.719%Add 4.51%19,159,633
MDTFirst Eagle Investment 2016-06-30 Reduce-0.14%$75 - $86.77
($80.78)
$ 87.719%Reduce -39.69%1,106,014
MDTDodge & Cox 2016-06-30 Reduce-0.03%$75 - $86.77
($80.78)
$ 87.719%Reduce -5.64%6,452,264
MDTGeorge Soros 2016-06-30 Sold Out -0.02%$75 - $86.77
($80.78)
$ 87.719%Sold Out0
MDTRuane Cunniff 2016-06-30 Reduce$75 - $86.77
($80.78)
$ 87.719%Reduce -12.84%3,395
MDTKen Fisher 2016-06-30 Reduce$75 - $86.77
($80.78)
$ 87.719%Reduce -6.02%4,716
MDTKeeley Asset Management Corp 2016-06-30 Reduce$75 - $86.77
($80.78)
$ 87.719%Reduce -8.54%11,133
MDTMario Gabelli 2016-06-30 Reduce$75 - $86.77
($80.78)
$ 87.719%Reduce -9.48%34,285
MDTBill Nygren 2016-03-31 Reduce-0.81%$72.62 - $77.66
($75.29)
$ 87.7116%Reduce -40.57%2,490,000
MDTHOTCHKIS & WILEY 2016-03-31 Reduce-0.47%$72.62 - $77.66
($75.29)
$ 87.7116%Reduce -38.83%2,374,011
MDTBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Reduce-0.32%$72.62 - $77.66
($75.29)
$ 87.7116%Reduce -9.21%27,494,507
MDTVanguard Health Care Fund 2016-03-31 Reduce-0.27%$72.62 - $77.66
($75.29)
$ 87.7116%Reduce -8.71%18,332,133
MDTRobert Olstein 2016-03-31 Reduce-0.12%$72.62 - $77.66
($75.29)
$ 87.7116%Reduce -11.11%96,000
MDTKeeley Asset Management Corp 2016-03-31 Reduce-0.03%$72.62 - $77.66
($75.29)
$ 87.7116%Reduce -51.85%12,172
MDTGeorge Soros 2016-03-31 Buy 0.02%$72.62 - $77.66
($75.29)
$ 87.7116%New holding11,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MDT is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MDT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Powell Kendall JDirector 2016-09-15Sell7,907$85.452.64view
ISHRAK OMARChairman & CEO 2016-09-15Sell61,925$84.933.27view
Hanson Bryan CEVP, President, MITG 2016-08-29Sell15,000$870.82view
Hanson Bryan CEVP, President, MITG 2016-07-26Sell15,000$870.82view
Martha GeoffreyEVP & GroupPres Restora Therap 2016-07-15Sell3,766$88.26-0.62view
Ellis Gary LeeEVP & Global Ops and IT 2016-07-13Sell35,495$88.64-1.05view
JACKSON SHIRLEY ADirector 2016-07-13Sell2,104$88.64-1.05view
Surface Carol ASVP, Chief HR Officer 2016-07-06Sell9,787$87.080.72view
Hanson Bryan CEVP, President, MITG 2016-07-05Sell15,272$87.110.69view
Kuntz RichardSrVP & Chief Scien, Clin, Reg 2016-06-03Sell49,905$82.66.19view

Quarterly/Annual Reports about MDT:

News about MDT:

Articles On GuruFocus.com
Barrow, Hanley, Mewhinney & Strauss Reduces Stakes in 2nd Quarter Sep 13 2016 
Dividend Aristocrat Correlation Pairs Aug 28 2016 
Jeff Auxier's Summer 2016 Market Commentary Aug 05 2016 
Gabelli Funds Comments on Medtronic Plc Aug 04 2016 
T. Rowe Price Buys Apple, Pepsi, Western Digital Jul 26 2016 
T. Rowe Price Ditches Domestic, Buys Foreign Jul 22 2016 
T Rowe Price Buys Apple and 2 Other Companies Jul 15 2016 
Baxter Well Positioned in Fast-Growing Market for Kidney Dialysis Equipment Jul 01 2016 
IBM's CEO Discusses Cognitive Computing Apr 10 2016 
The Conundrum in Health Care Investing Mar 06 2016 

More From Other Websites
ETF’s with exposure to Medtronic Plc : September 23, 2016 Sep 23 2016
Medtronic (MDT): Valiant Captivia Data Positive at Three Years Sep 23 2016
Medtronic Valiant Captivia Demonstrates Safety and Efficacy at Three Years Sep 20 2016
Medtronic Plc (MDT) Chairman & CEO Omar Ishrak Sold $5.3 million of Shares Sep 19 2016
New Data Presented in VIVA Late Breaking Clinical Trials Demonstrate Durability, Safety and Efficacy... Sep 19 2016
Analysis Shows Positive Association Between Cardiac Resynchronization Therapy and Patients'... Sep 19 2016
AxoGen, Inc. Appoints Amy Wendell to Board of Directors Sep 19 2016
Analyzing St. Jude Medical’s Latest Dividend Payment Sep 16 2016
Medtronic's Reveal Heart Monitor Launch in Japan Bodes Well Sep 15 2016
The Journal of the American Medical Association Publishes Medtronic's Hybrid Closed Loop System... Sep 15 2016
Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services Sep 15 2016
Today's Top 5 Stock Picks: Oshkosh, Unilever, More Sep 15 2016
Medtronic IN.PACT Admiral: First FDA-Approved DCB for ISR Sep 14 2016
Medtronic Announces Approval and Launch of Reveal LINQ(TM) Insertable Cardiac Monitor in Japan Sep 14 2016
Barrow, Hanley, Mewhinney & Strauss Reduces Stakes in 2nd Quarter Sep 13 2016
Perrenial Target and Acquirer NuVasive Names New President and COO Sep 13 2016
Medtronic Receives FDA Approval of First Drug-Coated Balloon for Treatment of In-Stent Restenosis... Sep 13 2016
New ESC Guidelines Support Recent Medtronic Innovations for Patients with Atrial Fibrillation Sep 12 2016
Medtronic’s Latest Analysts’ Recommendations Are Mostly ‘Buys’ Sep 12 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)